Amedeo Smart

Free Medical Literature Service


 

Amedeo

Vaccines

  Free Subscription

Articles published in
JAMA
    July 2022
  1. KIM YE, Huh K, Park YJ, Peck KR, et al
    Association Between Vaccination and Acute Myocardial Infarction and Ischemic Stroke After COVID-19 Infection.
    JAMA. 2022 Jul 22. pii: 2794753. doi: 10.1001/jama.2022.12992.
    >> Share

  2. LARKIN HD
    Mix-and-Match COVID-19 Boosters After Inactivated Virus Vaccine.
    JAMA. 2022;328:234.
    >> Share

  3. KUEHN BM
    Newer Poxvirus Vaccine Is Recommended.
    JAMA. 2022;328:123.
    >> Share

  4. AZZOLINI E, Levi R, Sarti R, Pozzi C, et al
    Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care Workers.
    JAMA. 2022 Jul 1. pii: 2794072. doi: 10.1001/jama.2022.11691.
    >> Share

    June 2022
  5. ABBASI J
    COVID-19 mRNA Vaccine Booster During Pregnancy Increases Maternal and Fetal Antibodies.
    JAMA. 2022 Jun 22. pii: 2793740. doi: 10.1001/jama.2022.11145.
    >> Share

  6. LARKIN HD
    mRNA COVID-19 Vaccine Booster After Inactivated Vaccine Primary Series.
    JAMA. 2022;327:2280.
    >> Share

  7. LARKIN HD
    Maternal RSV Vaccine Could Protect Infants, Interim Analysis Suggests.
    JAMA. 2022;327:2182.
    >> Share

  8. KATZ SE, Edwards K
    Protecting Children Against Omicron.
    JAMA. 2022;327:2195-2197.
    >> Share

  9. JONES JM, Opsomer JD, Stone M, Benoit T, et al
    Updated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Estimates Based on Blood Donations, July 2020-December 2021.
    JAMA. 2022 Jun 13. pii: 2793517. doi: 10.1001/jama.2022.9745.
    >> Share

  10. LI Y
    Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave.
    JAMA. 2022;327:2147-2148.
    >> Share

  11. TAI CG, Maragakis LL, Connolly S, DiFiori J, et al
    Association Between COVID-19 Booster Vaccination and Omicron Infection in a Highly Vaccinated Cohort of Players and Staff in the National Basketball Association.
    JAMA. 2022 Jun 2. pii: 2793169. doi: 10.1001/jama.2022.9479.
    >> Share

  12. RUBIN R
    Challenges of Deciding Whether and How to Update COVID-19 Vaccines to Protect Against Variants.
    JAMA. 2022 Jun 1. pii: 2793149. doi: 10.1001/jama.2022.9367.
    >> Share

    May 2022
  13. WEISS SR
    Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US.
    JAMA. 2022;327:2019-2020.
    >> Share

  14. OSTER ME, Shay DK, Shimabukuro TT
    Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US-Reply.
    JAMA. 2022;327:2020-2021.
    >> Share

  15. KUEHN BM
    Cardiac Complications More Common After COVID-19 Than Vaccination.
    JAMA. 2022;327:1951.
    >> Share

  16. FLEMING-DUTRA KE, Britton A, Shang N, Derado G, et al
    Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance.
    JAMA. 2022 May 13. pii: 2792524. doi: 10.1001/jama.2022.7493.
    >> Share

  17. DORABAWILA V, Hoefer D, Bauer UE, Bassett MT, et al
    Risk of Infection and Hospitalization Among Vaccinated and Unvaccinated Children and Adolescents in New York After the Emergence of the Omicron Variant.
    JAMA. 2022 May 13. pii: 2792525. doi: 10.1001/jama.2022.7319.
    >> Share

  18. LARKIN HD
    Four Vaccine Doses Prevented Severe Omicron COVID-19 Better Than 3.
    JAMA. 2022;327:1748.
    >> Share

  19. LARKIN HD
    Two mRNA COVID-19 Vaccines Stimulate Different Immune Responses.
    JAMA. 2022;327:1748.
    >> Share

  20. KUEHN BM
    Age Range Is Expanded for Universal Hepatitis B Vaccination.
    JAMA. 2022;327:1749.
    >> Share

  21. KUEHN BM
    mRNA Booster Improves a COVID-19 Vaccine's Effectiveness.
    JAMA. 2022;327:1749.
    >> Share

  22. SLOMSKI A
    Studies Examine Risk of Hearing Loss After COVID-19 Vaccination.
    JAMA. 2022;327:1641.
    >> Share

  23. MARKS P, Woodcock J, Califf R
    COVID-19 Vaccination-Becoming Part of the New Normal.
    JAMA. 2022 May 2. pii: 2792030. doi: 10.1001/jama.2022.7469.
    >> Share

    April 2022
  24. KUEHN BM
    COVID-19 Vaccine Effectiveness in Youth Varies by Age, Variant.
    JAMA. 2022;327:1540.
    >> Share

  25. RAZZAGHI H, Meghani M, Crane B, Ellington S, et al
    Receipt of COVID-19 Booster Dose Among Fully Vaccinated Pregnant Individuals Aged 18 to 49 Years by Key Demographics.
    JAMA. 2022 Apr 22. pii: 2791659. doi: 10.1001/jama.2022.6834.
    >> Share

  26. LARKIN HD
    Fractionating COVID-19 Vaccine Doses May Save Lives.
    JAMA. 2022;327:1438.
    >> Share

  27. WOLFSON AR, Freeman EE, Blumenthal KG
    Urticaria 12 Days After COVID-19 mRNA Booster Vaccination.
    JAMA. 2022 Apr 14. pii: 2791317. doi: 10.1001/jama.2022.5247.
    >> Share

  28. ABBASI J
    Large US Study Examines First 6 Months of COVID-19 Vaccine Safety Data.
    JAMA. 2022;327:1323.
    >> Share

  29. ABBASI J
    Vaccine Booster Dose Appears to Reduce Omicron Hospitalizations.
    JAMA. 2022;327:1323.
    >> Share

  30. KUEHN BM
    Myocarditis Adverse Event Less Common After COVID-19 Vaccine Booster.
    JAMA. 2022;327:1324.
    >> Share

  31. SLOMSKI A
    Maternal COVID-19 Vaccine Safe for Infants.
    JAMA. 2022;327:1218.
    >> Share

  32. NISSEN SE, Wolski K, Balog C, Swerdlow DI, et al
    Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels.
    JAMA. 2022 Apr 3. pii: 2790912. doi: 10.1001/jama.2022.5050.
    >> Share

  33. NATTINO G, Castiglioni S, Cereda D, Della Valle PG, et al
    Association Between SARS-CoV-2 Viral Load in Wastewater and Reported Cases, Hospitalizations, and Vaccinations in Milan, March 2020 to November 2021.
    JAMA. 2022 Apr 1. pii: 2790911. doi: 10.1001/jama.2022.4908.
    >> Share

    March 2022
  34. BRUXVOORT K, Slezak J, Qian L, Sy LS, et al
    Association Between 2-Dose vs 3-Dose Hepatitis B Vaccine and Acute Myocardial Infarction.
    JAMA. 2022 Mar 25. pii: 2790492. doi: 10.1001/jama.2022.2540.
    >> Share

  35. KHARBANDA EO, Vazquez-Benitez G
    COVID-19 mRNA Vaccines During Pregnancy: New Evidence to Help Address Vaccine Hesitancy.
    JAMA. 2022 Mar 24. pii: 2790610. doi: 10.1001/jama.2022.2459.
    >> Share

  36. MAGNUS MC, Ortqvist AK, Dahlqwist E, Ljung R, et al
    Association of SARS-CoV-2 Vaccination During Pregnancy With Pregnancy Outcomes.
    JAMA. 2022 Mar 24. pii: 2790608. doi: 10.1001/jama.2022.3271.
    >> Share

  37. FELL DB, Dhinsa T, Alton GD, Torok E, et al
    Association of COVID-19 Vaccination in Pregnancy With Adverse Peripartum Outcomes.
    JAMA. 2022 Mar 24. pii: 2790607. doi: 10.1001/jama.2022.4255.
    >> Share

  38. SLOMSKI A
    Pneumococcal Vaccine Induces Immune Responses to 20 Serotypes.
    JAMA. 2022;327:1118.
    >> Share

  39. STEAD W
    One Person.
    JAMA. 2022;327:1131-1132.
    >> Share

  40. FRIEDENSOHN L, Levin D, Fadlon-Derai M, Gershovitz L, et al
    Myocarditis Following a Third BNT162b2 Vaccination Dose in Military Recruits in Israel.
    JAMA. 2022 Mar 17. pii: 2790421. doi: 10.1001/jama.2022.4425.
    >> Share

  41. ABBASI J
    First mRNA HIV Vaccine Clinical Trial Launches.
    JAMA. 2022;327:909.
    >> Share

  42. KUEHN BM
    Racial and Ethnic, Gender Disparities Seen in LGBT COVID-19 Vaccination Rates.
    JAMA. 2022;327:910.
    >> Share

    February 2022
  43. ABBASI J
    Widespread Misinformation About Infertility Continues to Create COVID-19 Vaccine Hesitancy.
    JAMA. 2022 Feb 22. pii: 2789477. doi: 10.1001/jama.2022.2404.
    >> Share

  44. KUEHN BM
    New COVID-19 Vaccine Aims to Increase Global Vaccine Access.
    JAMA. 2022;327:614.
    >> Share

  45. KUEHN BM
    COVID-19 Vaccines Safe, Effective in Rheumatic Diseases.
    JAMA. 2022;327:614.
    >> Share

  46. BRITTON A, Fleming-Dutra KE, Shang N, Smith ZR, et al
    Association of COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection by Time Since Vaccination and Delta Variant Predominance.
    JAMA. 2022 Feb 14. pii: 2789294. doi: 10.1001/jama.2022.2068.
    >> Share

  47. TAN SHX, Pung R, Wang LF, Lye DC, et al
    Association of Homologous and Heterologous Vaccine Boosters With COVID-19 Incidence and Severity in Singapore.
    JAMA. 2022 Feb 11. pii: 2789151. doi: 10.1001/jama.2022.1922.
    >> Share

  48. ABBASI J
    Fourth COVID-19 Vaccine Dose Increases Low Antibodies.
    JAMA. 2022;327:517.
    >> Share

  49. KUEHN BM
    Health Care Professionals' Advice Can Increase COVID-19 Vaccination.
    JAMA. 2022;327:518.
    >> Share

  50. SHOOK LL, Atyeo CG, Yonker LM, Fasano A, et al
    Durability of Anti-Spike Antibodies in Infants After Maternal COVID-19 Vaccination or Natural Infection.
    JAMA. 2022 Feb 7. pii: 2788986. doi: 10.1001/jama.2022.1206.
    >> Share

    January 2022
  51. SURAN M
    Coverage of COVID-19 Vaccine Counseling for Children and Youths.
    JAMA. 2022;327:313.
    >> Share

  52. LI HF, Hu SM, Lv M
    Association of Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barre Syndrome.
    JAMA. 2022;327:392-393.
    >> Share

  53. WOO EJ, Dimova RB, Mba-Jonas A
    Presumptive Guillain-Barre Syndrome Associated With Receipt of the Ad26.COV2.2.S COVID-19 Vaccine-Reply.
    JAMA. 2022;327:393-394.
    >> Share

  54. OSTER ME, Shay DK, Su JR, Gee J, et al
    Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021.
    JAMA. 2022;327:331-340.
    >> Share

  55. KLOMPAS M, Karan A
    Preventing SARS-CoV-2 Transmission in Health Care Settings in the Context of the Omicron Variant.
    JAMA. 2022 Jan 24. pii: 2788503. doi: 10.1001/jama.2022.0262.
    >> Share

  56. ABBASI J, Rubin R, Suran M
    How the Supreme Court's COVID-19 Vaccine Mandate Rulings Could Shape the Pandemic's Next Phase.
    JAMA. 2022 Jan 21. pii: 2788486. doi: 10.1001/jama.2022.0791.
    >> Share

  57. OMER SB, Malani PN
    Booster Vaccination to Prevent COVID-19 in the Era of Omicron: An Effective Part of a Layered Public Health Approach.
    JAMA. 2022 Jan 21. pii: 2788487. doi: 10.1001/jama.2022.0892.
    >> Share

  58. GOSTIN LO, Parmet WE, Rosenbaum S
    The US Supreme Court's Rulings on Large Business and Health Care Worker Vaccine Mandates: Ramifications for the COVID-19 Response and the Future of Federal Public Health Protection.
    JAMA. 2022 Jan 21. pii: 2788481. doi: 10.1001/jama.2022.0852.
    >> Share

  59. ACCORSI EK, Britton A, Fleming-Dutra KE, Smith ZR, et al
    Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
    JAMA. 2022 Jan 21. pii: 2788485. doi: 10.1001/jama.2022.0470.
    >> Share

  60. WANG L, Davis PB, Kaelber DC, Volkow ND, et al
    Comparison of mRNA-1273 and BNT162b2 Vaccines on Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Death During the Delta-Predominant Period.
    JAMA. 2022 Jan 20. pii: 2788408. doi: 10.1001/jama.2022.0210.
    >> Share

  61. KUEHN BM
    Vaccine Development Is Charting a New Path in Malaria Control.
    JAMA. 2022 Jan 19. pii: 2788387. doi: 10.1001/jama.2021.20627.
    >> Share

  62. KUEHN BM
    Vaccine Passports Help Boost Lagging Vaccination Rates.
    JAMA. 2022;327:209.
    >> Share

  63. ADASHI EY, Cohen IG
    The Pandemic Preparedness Program: Reimagining Public Health.
    JAMA. 2022;327:219-220.
    >> Share

  64. ABBASI J
    Former Biden-Harris Transition Advisors Propose a New National Strategy for COVID-19.
    JAMA. 2022 Jan 18. pii: 2788316. doi: 10.1001/jama.2022.0216.
    >> Share

  65. RUBIN R
    COVID-19 Vaccines Have Been Available in the US for More Than a Year-What's Been Learned and What's Next?
    JAMA. 2022 Jan 11. pii: 2788213. doi: 10.1001/jama.2022.0106.
    >> Share

  66. ABBASI J
    Studies Suggest COVID-19 Vaccine Boosters Save Lives.
    JAMA. 2022;327:115.
    >> Share

  67. ABBASI J
    Homing In On a SARS-CoV-2 Correlate of Protection.
    JAMA. 2022;327:115.
    >> Share

  68. ABBASI J
    COVID-19 Vaccine Focused on T-Cell Response Promising in Early Trial.
    JAMA. 2022;327:115.
    >> Share

  69. WALD A
    Booster Vaccination to Reduce SARS-CoV-2 Transmission and Infection.
    JAMA. 2022 Jan 10. pii: 2788105. doi: 10.1001/jama.2021.23726.
    >> Share

  70. SPITZER A, Angel Y, Marudi O, Zeltser D, et al
    Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel.
    JAMA. 2022 Jan 10. pii: 2788104. doi: 10.1001/jama.2021.23641.
    >> Share

  71. BORIO LL, Bright RA, Emanuel EJ
    A National Strategy for COVID-19 Medical Countermeasures: Vaccines and Therapeutics.
    JAMA. 2022 Jan 6. pii: 2787946. doi: 10.1001/jama.2021.24165.
    >> Share

    December 2021
  72. ABBASI J
    RSV Vaccines, Finally Within Reach, Could Prevent Tens of Thousands of Yearly Deaths.
    JAMA. 2021 Dec 29. pii: 2787757. doi: 10.1001/jama.2021.23772.
    >> Share


  73. Two New Pneumococcal Vaccines-Prevnar 20 and Vaxneuvance.
    JAMA. 2021;326:2521-2522.
    >> Share

  74. SLOMSKI A
    More Pediatric Data for First Cell-Derived Influenza Vaccine.
    JAMA. 2021;326:2464.
    >> Share

  75. KUEHN BM
    Influenza Vaccination Increased During the COVID-19 Pandemic.
    JAMA. 2021;326:2465.
    >> Share

  76. ABBASI J
    Omicron Has Reached the US-Here's What Infectious Disease Experts Know About the Variant.
    JAMA. 2021;326:2460-2462.
    >> Share

  77. LAM DL, Flanagan MR
    Axillary Lymphadenopathy After COVID-19 Vaccination in a Woman With Breast Cancer.
    JAMA. 2021 Dec 23. pii: 2787650. doi: 10.1001/jama.2021.20010.
    >> Share

  78. DEL RIO C, Omer SB, Malani PN
    Winter of Omicron-The Evolving COVID-19 Pandemic.
    JAMA. 2021 Dec 22. pii: 2787609. doi: 10.1001/jama.2021.24315.
    >> Share

  79. KUEHN BM
    Vaccination Doesn't Eliminate Delta Variant Household Transmission.
    JAMA. 2021;326:2353.
    >> Share

  80. COHN AC, Mahon BE, Walensky RP
    One Year of COVID-19 Vaccines: A Shot of Hope, a Dose of Reality.
    JAMA. 2021 Dec 21. pii: 2787504. doi: 10.1001/jama.2021.23962.
    >> Share

  81. LEVY M, Recher M, Hubert H, Javouhey E, et al
    Multisystem Inflammatory Syndrome in Children by COVID-19 Vaccination Status of Adolescents in France.
    JAMA. 2021 Dec 20. pii: 2787495. doi: 10.1001/jama.2021.23262.
    >> Share

  82. ADAMS LE, Waterman S, Paz-Bailey G
    Vaccination for Dengue Prevention.
    JAMA. 2021 Dec 16. pii: 2787445. doi: 10.1001/jama.2021.23466.
    >> Share

  83. BATES TA, McBride SK, Winders B, Schoen D, et al
    Antibody Response and Variant Cross-Neutralization After SARS-CoV-2 Breakthrough Infection.
    JAMA. 2021 Dec 16. pii: 2787447. doi: 10.1001/jama.2021.22898.
    >> Share

  84. SURAN M
    Why Parents Still Hesitate to Vaccinate Their Children Against COVID-19.
    JAMA. 2021 Dec 15. pii: 2787289. doi: 10.1001/jama.2021.21625.
    >> Share

  85. ABBASI J
    COVID-19 Vaccine Combination Was Superior in Real-world Study.
    JAMA. 2021;326:2250.
    >> Share

  86. WALTER K
    COVID-19 and Pregnancy.
    JAMA. 2021 Dec 10. pii: 2787240. doi: 10.1001/jama.2021.22679.
    >> Share


  87. Current Comment.
    JAMA. 2021;326:2217.
    >> Share

  88. GRUNAU B, Goldfarb DM, Asamoah-Boaheng M, Golding L, et al
    Immunogenicity of Extended mRNA SARS-CoV-2 Vaccine Dosing Intervals.
    JAMA. 2021 Dec 3. pii: 2786992. doi: 10.1001/jama.2021.21921.
    >> Share

  89. ABBASI J
    Data Emerge From the UK's COVID-19 Vaccine Extended Dosing Interval.
    JAMA. 2021 Dec 3. pii: 2786993. doi: 10.1001/jama.2021.21963.
    >> Share

  90. FERNANDES B, Navin MC, Reiss DR, Omer SB, et al
    US State-Level Legal Interventions Related to COVID-19 Vaccine Mandates.
    JAMA. 2021 Dec 2. pii: 2786984. doi: 10.1001/jama.2021.22122.
    >> Share

    November 2021
  91. RUBIN R
    COVID-19 Vaccine Makers Plan for Annual Boosters, but It's Not Clear They'll Be Needed.
    JAMA. 2021 Nov 24. pii: 2786818. doi: 10.1001/jama.2021.21291.
    >> Share

  92. RUBIN R
    Substance Use Disorders and COVID-19 Vaccine Response.
    JAMA. 2021;326:2000.
    >> Share

  93. KUEHN BM
    COVID-19 Vaccine Highly Effective Against Adolescent Hospitalizations.
    JAMA. 2021;326:2002.
    >> Share

  94. KUEHN BM
    Unhygienic Practices Lead to Routine Vaccination-Linked Infections.
    JAMA. 2021;326:2002.
    >> Share

  95. JABAGI MJ, Botton J, Bertrand M, Weill A, et al
    Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older.
    JAMA. 2021 Nov 22. pii: 2786667. doi: 10.1001/jama.2021.21699.
    >> Share

  96. SFEIR MM, Snayd M
    Serologic Testing for Hepatitis B.
    JAMA. 2021 Nov 19. pii: 2786654. doi: 10.1001/jama.2021.19803.
    >> Share

  97. CHOR J, Davis AM, Rusiecki JM
    Cervical Cancer Screening Guideline for Individuals at Average Risk.
    JAMA. 2021 Nov 12. pii: 2786400. doi: 10.1001/jama.2021.13448.
    >> Share

  98. ABBASI J
    Flu Vaccine Candidate Elicits Enhanced Immune Response.
    JAMA. 2021;326:1784.
    >> Share

  99. ABBASI J
    Pfizer Launches Phase 1 mRNA Flu Vaccine Trial.
    JAMA. 2021;326:1784.
    >> Share

  100. ABBASI J
    "Polymutant" Spike Points Way Toward More Durable COVID-19 Vaccine.
    JAMA. 2021;326:1784.
    >> Share


  101. Routine Smallpox Vaccination.
    JAMA. 2021;326:1876.
    >> Share

  102. ELIAKIM-RAZ N, Leibovici-Weisman Y, Stemmer A, Ness A, et al
    Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Adults Aged >/=60 Years.
    JAMA. 2021 Nov 5. pii: 2786096. doi: 10.1001/jama.2021.19885.
    >> Share

  103. MOSS WJ, Gostin LO, Nuzzo JB
    Pediatric COVID-19 Vaccines: What Parents, Practitioners, and Policy Makers Need to Know.
    JAMA. 2021 Nov 5. pii: 2786095. doi: 10.1001/jama.2021.20734.
    >> Share

  104. KLOMPAS M
    Understanding Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination.
    JAMA. 2021 Nov 4. pii: 2786040. doi: 10.1001/jama.2021.19063.
    >> Share

  105. TENFORDE MW, Self WH, Adams K, Gaglani M, et al
    Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.
    JAMA. 2021 Nov 4. pii: 2786039. doi: 10.1001/jama.2021.19499.
    >> Share

  106. CROWE EH
    The Taste of Hope.
    JAMA. 2021;326:1683-1684.
    >> Share

  107. ZHONG D, Xiao S, Debes AK, Egbert ER, et al
    Durability of Antibody Levels After Vaccination With mRNA SARS-CoV-2 Vaccine in Individuals With or Without Prior Infection.
    JAMA. 2021 Nov 1. pii: 2785919. doi: 10.1001/jama.2021.19996.
    >> Share

  108. ABU-RADDAD LJ, Chemaitelly H, Ayoub HH, Yassine HM, et al
    Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar.
    JAMA. 2021 Nov 1. pii: 2785918. doi: 10.1001/jama.2021.19623.
    >> Share

    October 2021
  109. ABBASI J
    The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity.
    JAMA. 2021 Oct 21. pii: 2785530. doi: 10.1001/jama.2021.18919.
    >> Share

  110. RUBIN R
    Trying to Block SARS-CoV-2 Transmission With Intranasal Vaccines.
    JAMA. 2021 Oct 14. pii: 2785303. doi: 10.1001/jama.2021.18143.
    >> Share

  111. SZILAGYI PG, Thomas K, Shah MD, Vizueta N, et al
    Changes in COVID-19 Vaccine Intent From April/May to June/July 2021.
    JAMA. 2021 Oct 13. pii: 2785290. doi: 10.1001/jama.2021.18761.
    >> Share

  112. ABBASI J
    India's New COVID-19 DNA Vaccine for Adolescents and Adults Is a First.
    JAMA. 2021;326:1365.
    >> Share

  113. ABBASI J
    Moderna's mRNA Vaccine for Seasonal Flu Enters Clinical Trials.
    JAMA. 2021;326:1365.
    >> Share

  114. ABBASI J
    Vaccine-Induced SARS-CoV-2 Antibodies in Inflammatory Diseases.
    JAMA. 2021;326:1365.
    >> Share

  115. KUEHN BM
    HPV Vaccination Coverage Has Increased Among Adolescents.
    JAMA. 2021;326:1366.
    >> Share

  116. WOO EJ, Mba-Jonas A, Dimova RB, Alimchandani M, et al
    Association of Receipt of the Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barre Syndrome, February-July 2021.
    JAMA. 2021 Oct 7. pii: 2785009. doi: 10.1001/jama.2021.16496.
    >> Share

    September 2021
  117. RUBIN R
    COVID-19 Vaccine Nasal Spray.
    JAMA. 2021;326:1138.
    >> Share

  118. KRONMAL SL
    Shots in Arms.
    JAMA. 2021;326:1151-1152.
    >> Share

  119. ABBASI J
    SARS-CoV-2 Variant Antibodies Wane 6 Months After Vaccination.
    JAMA. 2021;326:901.
    >> Share

  120. KUEHN BM
    Adolescent Myocarditis After COVID-19 Vaccination Is Rare.
    JAMA. 2021;326:902.
    >> Share

  121. KHARBANDA EO, Haapala J, DeSilva M, Vazquez-Benitez G, et al
    Spontaneous Abortion Following COVID-19 Vaccination During Pregnancy.
    JAMA. 2021 Sep 8. pii: 2784193. doi: 10.1001/jama.2021.15494.
    >> Share

  122. SLOMSKI A
    Most Fully Vaccinated Patients With Cancer Have SARS-CoV-2 Antibodies.
    JAMA. 2021;326:800.
    >> Share

  123. BLUMENTHAL KG, Phadke NA, Bates DW
    Safety Surveillance of COVID-19 mRNA Vaccines Through the Vaccine Safety Datalink.
    JAMA. 2021 Sep 3. pii: 2784017. doi: 10.1001/jama.2021.14808.
    >> Share

  124. KLEIN NP, Lewis N, Goddard K, Fireman B, et al
    Surveillance for Adverse Events After COVID-19 mRNA Vaccination.
    JAMA. 2021 Sep 3. pii: 2784015. doi: 10.1001/jama.2021.15072.
    >> Share

  125. JONES JM, Stone M, Sulaeman H, Fink RV, et al
    Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.
    JAMA. 2021 Sep 2. pii: 2784013. doi: 10.1001/jama.2021.15161.
    >> Share

    August 2021
  126. STEENSELS D, Pierlet N, Penders J, Mesotten D, et al
    Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273.
    JAMA. 2021 Aug 30. pii: 2783797. doi: 10.1001/jama.2021.15125.
    >> Share

  127. RUBIN R
    Influenza's Unprecedented Low Profile During COVID-19 Pandemic Leaves Experts Wondering What This Flu Season Has in Store.
    JAMA. 2021 Aug 25. pii: 2783644. doi: 10.1001/jama.2021.14131.
    >> Share

  128. DETSKY AS, Bogoch II
    COVID-19 in Canada: Experience and Response to Waves 2 and 3.
    JAMA. 2021 Aug 23. pii: 2783610. doi: 10.1001/jama.2021.14797.
    >> Share

  129. DEL RIO C, Malani PN, Omer SB
    Confronting the Delta Variant of SARS-CoV-2, Summer 2021.
    JAMA. 2021 Aug 18. pii: 2783478. doi: 10.1001/jama.2021.14811.
    >> Share

  130. EVANS A, Webster J, Flores G
    Partnering With the Faith-Based Community to Address Disparities in COVID-19 Vaccination Rates and Outcomes Among US Black and Latino Populations.
    JAMA. 2021;326:609-610.
    >> Share

  131. SCHAEFER GO, Leland RJ, Emanuel EJ
    Making Vaccines Available to Other Countries Before Offering Domestic Booster Vaccinations.
    JAMA. 2021 Aug 12. pii: 2783234. doi: 10.1001/jama.2021.13226.
    >> Share

  132. ABBASI J
    Oldest Adults Need 2 mRNA Vaccine Doses to Neutralize SARS-CoV-2.
    JAMA. 2021;326:473.
    >> Share

  133. ABBASI J
    COVID-19 mRNA Vaccines Blunt Breakthrough Infection Severity.
    JAMA. 2021;326:473.
    >> Share

  134. DIAZ GA, Parsons GT, Gering SK, Meier AR, et al
    Myocarditis and Pericarditis After Vaccination for COVID-19.
    JAMA. 2021 Aug 4. pii: 2782900. doi: 10.1001/jama.2021.13443.
    >> Share

    July 2021
  135. ABBASI J
    Uberantibodies From Recovered COVID-19 Patients Could Spur New Therapeutics and Vaccines.
    JAMA. 2021 Jul 28. pii: 2782673. doi: 10.1001/jama.2021.12915.
    >> Share

  136. RUBIN R
    Higher Medicare Payments for In-home COVID-19 Vaccinations.
    JAMA. 2021;326:298.
    >> Share

  137. KUEHN BM
    Resurgence of Pertussis Linked With Switch to Acellular Vaccine.
    JAMA. 2021;326:300.
    >> Share

  138. BENOTMANE I, Gautier G, Perrin P, Olagne J, et al
    Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses.
    JAMA. 2021 Jul 23. pii: 2782538. doi: 10.1001/jama.2021.12339.
    >> Share

  139. BATES TA, Leier HC, Lyski ZL, Goodman JR, et al
    Age-Dependent Neutralization of SARS-CoV-2 and P.1 Variant by Vaccine Immune Serum Samples.
    JAMA. 2021 Jul 21. pii: 2782428. doi: 10.1001/jama.2021.11656.
    >> Share

  140. ABBASI J
    Study Suggests Lasting Immunity After COVID-19, With a Big Boost From Vaccination.
    JAMA. 2021 Jul 14. pii: 2782139. doi: 10.1001/jama.2021.11717.
    >> Share

  141. GOLDSHTEIN I, Nevo D, Steinberg DM, Rotem RS, et al
    Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women.
    JAMA. 2021 Jul 12. pii: 2782047. doi: 10.1001/jama.2021.11035.
    >> Share

  142. NUTI SV, Armstrong K
    Lay Epidemiology and Vaccine Acceptance.
    JAMA. 2021 Jul 7. pii: 2781943. doi: 10.1001/jama.2021.11130.
    >> Share

  143. WALKEY AJ, Law A, Bosch NA
    Lottery-Based Incentive in Ohio and COVID-19 Vaccination Rates.
    JAMA. 2021 Jul 2. pii: 2781792. doi: 10.1001/jama.2021.11048.
    >> Share

  144. SANCHEZ VAN KAMMEN M, Heldner MR, Brodard J, Scutelnic A, et al
    Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic.
    JAMA. 2021 Jul 2. pii: 2781791. doi: 10.1001/jama.2021.9889.
    >> Share

  145. KAVANAGH MM, Gostin LO, Sunder M
    Sharing Technology and Vaccine Doses to Address Global Vaccine Inequity and End the COVID-19 Pandemic.
    JAMA. 2021 Jul 1. pii: 2781756. doi: 10.1001/jama.2021.10823.
    >> Share

  146. PERSAD G, Emanuel EJ
    Ethical Considerations of Offering Benefits to COVID-19 Vaccine Recipients.
    JAMA. 2021 Jul 1. pii: 2781755. doi: 10.1001/jama.2021.11045.
    >> Share

    June 2021
  147. RUBIN R
    The Search for a Single Vaccine Against Coronaviruses Yet to Come.
    JAMA. 2021 Jun 23. pii: 2781521. doi: 10.1001/jama.2021.9477.
    >> Share

  148. RUBIN R
    Vaccination in Residential Facilities.
    JAMA. 2021;325:2426.
    >> Share

  149. GONZALEZ DC, Nassau DE, Khodamoradi K, Ibrahim E, et al
    Sperm Parameters Before and After COVID-19 mRNA Vaccination.
    JAMA. 2021 Jun 17. pii: 2781360. doi: 10.1001/jama.2021.9976.
    >> Share

  150. BERTOLLINI R, Chemaitelly H, Yassine HM, Al-Thani MH, et al
    Associations of Vaccination and of Prior Infection With Positive PCR Test Results for SARS-CoV-2 in Airline Passengers Arriving in Qatar.
    JAMA. 2021 Jun 9. pii: 2781112. doi: 10.1001/jama.2021.9970.
    >> Share

  151. AZZIZ-BAUMGARTNER E, Grohskopf L, Patel M
    Realizing the Potential of Maternal Influenza Vaccination.
    JAMA. 2021;325:2257-2259.
    >> Share

  152. MEHRABADI A, Dodds L, MacDonald NE, Top KA, et al
    Association of Maternal Influenza Vaccination During Pregnancy With Early Childhood Health Outcomes.
    JAMA. 2021;325:2285-2293.
    >> Share

  153. TALBOT TR
    COVID-19 Vaccination of Health Care Personnel as a Condition of Employment: A Logical Addition to Institutional Safety Programs.
    JAMA. 2021 Jun 7. pii: 2781011. doi: 10.1001/jama.2021.8901.
    >> Share

  154. GOSTIN LO, Shaw J, Salmon DA
    Mandatory SARS-CoV-2 Vaccinations in K-12 Schools, Colleges/Universities, and Businesses.
    JAMA. 2021 Jun 7. pii: 2781010. doi: 10.1001/jama.2021.9342.
    >> Share

  155. RYAN L
    Vaccinated but Not Protected-Living Immunocompromised During the Pandemic.
    JAMA. 2021 Jun 7. pii: 2781012. doi: 10.1001/jama.2021.9321.
    >> Share

  156. WOOD S, Schulman K
    When Vaccine Apathy, Not Hesitancy, Drives Vaccine Disinterest.
    JAMA. 2021 Jun 2. pii: 2780792. doi: 10.1001/jama.2021.7707.
    >> Share

    May 2021
  157. HOTEZ PJ, Narayan KMV
    Restoring Vaccine Diplomacy.
    JAMA. 2021 May 28. pii: 2780640. doi: 10.1001/jama.2021.7439.
    >> Share

  158. AL KAABI N, Zhang Y, Xia S, Yang Y, et al
    Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial.
    JAMA. 2021 May 26. pii: 2780562. doi: 10.1001/jama.2021.8565.
    >> Share

  159. RUBIN R
    Allergic Reactions to mRNA Vaccines.
    JAMA. 2021;325:2038.
    >> Share

  160. DALY M, Jones A, Robinson E
    Public Trust and Willingness to Vaccinate Against COVID-19 in the US From October 14, 2020, to March 29, 2021.
    JAMA. 2021 May 24. pii: 2780519. doi: 10.1001/jama.2021.8246.
    >> Share

  161. UYEKI TM, Wentworth DE, Jernigan DB
    Influenza Activity in the US During the 2020-2021 Season.
    JAMA. 2021 May 24. pii: 2780518. doi: 10.1001/jama.2021.6125.
    >> Share

  162. COLLIER AY, McMahan K, Yu J, Tostanoski LH, et al
    Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women.
    JAMA. 2021 May 13. pii: 2780202. doi: 10.1001/jama.2021.7563.
    >> Share

  163. ABBASI J
    Personalized Cancer Vaccine Approach Safe in Early Trial.
    JAMA. 2021;325:1825.
    >> Share

  164. KUEHN BM
    Even Partial COVID-19 Vaccination Protects Nursing Home Residents.
    JAMA. 2021;325:1826.
    >> Share

  165. KUEHN BM
    Vaccine Dramatically Reduces HPV Infection Among Young Women.
    JAMA. 2021;325:1826.
    >> Share

  166. TANG L, Hijano DR, Gaur AH, Geiger TL, et al
    Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce.
    JAMA. 2021 May 6. pii: 2779854. doi: 10.1001/jama.2021.6564.
    >> Share

  167. ANGEL Y, Spitzer A, Henig O, Saiag E, et al
    Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.
    JAMA. 2021 May 6. pii: 2779853. doi: 10.1001/jama.2021.7152.
    >> Share

  168. BOYARSKY BJ, Werbel WA, Avery RK, Tobian AAR, et al
    Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients.
    JAMA. 2021 May 5. pii: 2779852. doi: 10.1001/jama.2021.7489.
    >> Share

    April 2021
  169. SEE I, Su JR, Lale A, Woo EJ, et al
    US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021.
    JAMA. 2021 Apr 30. pii: 2779731. doi: 10.1001/jama.2021.7517.
    >> Share

  170. KARRON RA, Key NS, Sharfstein JM
    Assessing a Rare and Serious Adverse Event Following Administration of the Ad26.COV2.S Vaccine.
    JAMA. 2021 Apr 30. pii: 2779732. doi: 10.1001/jama.2021.7637.
    >> Share

  171. RUBIN R
    Vaccination Priorities Delay Shots for Higher-Risk People of Color.
    JAMA. 2021;325:1601.
    >> Share

  172. RUBIN R
    Medicare Raises Payment for Administering COVID-19 Vaccines.
    JAMA. 2021;325:1601.
    >> Share

  173. CHEN MM, Mott N, Clark SJ, Harper DM, et al
    HPV Vaccination Among Young Adults in the US.
    JAMA. 2021;325:1673-1674.
    >> Share

  174. KUEHN BM
    Israel's Real-life Evidence That Vaccine Can Prevent Severe COVID-19.
    JAMA. 2021;325:1603.
    >> Share

  175. BLAIN H, Tuaillon E, Gamon L, Pisoni A, et al
    Spike Antibody Levels of Nursing Home Residents With or Without Prior COVID-19 3 Weeks After a Single BNT162b2 Vaccine Dose.
    JAMA. 2021 Apr 15. pii: 2778926. doi: 10.1001/jama.2021.6042.
    >> Share


  176. Experts Discuss COVID-19-Variants and Vaccine Efficacy, Immunosuppressed Patients, and More.
    JAMA. 2021 Apr 14. pii: 2778876. doi: 10.1001/jama.2021.5938.
    >> Share

  177. ABBASI J
    Data Leak Exposes Early COVID-19 Vaccine Manufacturing Hiccups.
    JAMA. 2021;325:1385.
    >> Share

  178. PERL SH, Uzan-Yulzari A, Klainer H, Asiskovich L, et al
    SARS-CoV-2-Specific Antibodies in Breast Milk After COVID-19 Vaccination of Breastfeeding Women.
    JAMA. 2021 Apr 12. pii: 2778766. doi: 10.1001/jama.2021.5782.
    >> Share

  179. GOSTIN LO, Cohen IG, Shaw J
    Digital Health Passes in the Age of COVID-19: Are "Vaccine Passports" Lawful and Ethical?
    JAMA. 2021 Apr 7. pii: 2778526. doi: 10.1001/jama.2021.5283.
    >> Share

  180. CHAPIN-BARDALES J, Gee J, Myers T
    Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines.
    JAMA. 2021 Apr 5. pii: 2778441. doi: 10.1001/jama.2021.5374.
    >> Share

    March 2021
  181. RUBIN R
    HHS Expands Number of People Who Can Vaccinate Against COVID-19.
    JAMA. 2021;325:1134.
    >> Share

  182. GOSTIN LO
    The Coronavirus Pandemic 1 Year On-What Went Wrong?
    JAMA. 2021;325:1132-1133.
    >> Share

  183. EDARA VV, Hudson WH, Xie X, Ahmed R, et al
    Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination.
    JAMA. 2021 Mar 19. pii: 2777898. doi: 10.1001/jama.2021.4388.
    >> Share


  184. Experts Discuss COVID-19-Vaccine Questions, School Openings, and More.
    JAMA. 2021 Mar 17. pii: 2777786. doi: 10.1001/jama.2021.4121.
    >> Share

  185. RUBIN R
    COVID-19 Vaccines vs Variants-Determining How Much Immunity Is Enough.
    JAMA. 2021 Mar 17. pii: 2777785. doi: 10.1001/jama.2021.3370.
    >> Share

  186. WILENSKY GR
    2020 Revealed How Poorly the US Was Prepared for COVID-19-and Future Pandemics.
    JAMA. 2021;325:1029-1030.
    >> Share

  187. BOYARSKY BJ, Werbel WA, Avery RK, Tobian AAR, et al
    Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients.
    JAMA. 2021 Mar 15. pii: 2777685. doi: 10.1001/jama.2021.4385.
    >> Share

  188. WILF-MIRON R, Myers V, Saban M
    Incentivizing Vaccination Uptake: The "Green Pass" Proposal in Israel.
    JAMA. 2021 Mar 15. pii: 2777686. doi: 10.1001/jama.2021.4300.
    >> Share

  189. STEPHENSON KE, Le Gars M, Sadoff J, de Groot AM, et al
    Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19.
    JAMA. 2021 Mar 11. pii: 2777598. doi: 10.1001/jama.2021.3645.
    >> Share

  190. CHRISTIE A, Mbaeyi SA, Walensky RP
    CDC Interim Recommendations for Fully Vaccinated People: An Important First Step.
    JAMA. 2021 Mar 10. pii: 2777536. doi: 10.1001/jama.2021.4367.
    >> Share

  191. BLUMENTHAL KG, Robinson LB, Camargo CA Jr, Shenoy ES, et al
    Acute Allergic Reactions to mRNA COVID-19 Vaccines.
    JAMA. 2021 Mar 8. pii: 2777417. doi: 10.1001/jama.2021.3976.
    >> Share

  192. MOORE JP
    Approaches for Optimal Use of Different COVID-19 Vaccines: Issues of Viral Variants and Vaccine Efficacy.
    JAMA. 2021 Mar 4. pii: 2777390. doi: 10.1001/jama.2021.3465.
    >> Share

  193. DEL RIO C, Malani P
    COVID-19 in 2021-Continuing Uncertainty.
    JAMA. 2021 Mar 4. pii: 2777391. doi: 10.1001/jama.2021.3760.
    >> Share

  194. MURRAY CJL, Piot P
    The Potential Future of the COVID-19 Pandemic: Will SARS-CoV-2 Become a Recurrent Seasonal Infection?
    JAMA. 2021 Mar 3. pii: 2777343. doi: 10.1001/jama.2021.2828.
    >> Share

  195. SAADAT S, Tehrani ZR, Logue J, Newman M, et al
    Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2.
    JAMA. 2021 Mar 1. pii: 2777171. doi: 10.1001/jama.2021.3341.
    >> Share

  196. LIVINGSTON EH, Malani PN, Creech CB
    The Johnson & Johnson Vaccine for COVID-19.
    JAMA. 2021 Mar 1. pii: 2777172. doi: 10.1001/jama.2021.2927.
    >> Share

    February 2021
  197. CREECH CB, Walker SC, Samuels RJ
    SARS-CoV-2 Vaccines.
    JAMA. 2021 Feb 26. pii: 2777059. doi: 10.1001/jama.2021.3199.
    >> Share

  198. GHARPURE R, Patel A, Link-Gelles R
    First-Dose COVID-19 Vaccination Coverage Among Skilled Nursing Facility Residents and Staff.
    JAMA. 2021 Feb 24. pii: 2777023. doi: 10.1001/jama.2021.2352.
    >> Share

  199. RUBIN R
    Pregnant People's Paradox-Excluded From Vaccine Trials Despite Having a Higher Risk of COVID-19 Complications.
    JAMA. 2021 Feb 24. pii: 2777024. doi: 10.1001/jama.2021.2264.
    >> Share

  200. RUBIN R
    The Price of Success-How to Evaluate COVID-19 Vaccines When They're Available Outside of Clinical Trials.
    JAMA. 2021 Feb 18. pii: 2776787. doi: 10.1001/jama.2021.0641.
    >> Share

  201. WALENSKY RP, Walke HT, Fauci AS
    SARS-CoV-2 Variants of Concern in the United States-Challenges and Opportunities.
    JAMA. 2021 Feb 17. pii: 2776739. doi: 10.1001/jama.2021.2294.
    >> Share

  202. KUEHN BM
    High-Income Countries Have Secured the Bulk of COVID-19 Vaccines.
    JAMA. 2021;325:612.
    >> Share

  203. SHARFSTEIN JM, Goodman JL, Borio L
    The US Regulatory System and COVID-19 Vaccines: The Importance of a Strong and Capable FDA.
    JAMA. 2021 Feb 15. pii: 2776658. doi: 10.1001/jama.2021.1961.
    >> Share

  204. SHIMABUKURO TT, Cole M, Su JR
    Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US-December 14, 2020-January 18, 2021.
    JAMA. 2021 Feb 12. pii: 2776557. doi: 10.1001/jama.2021.1967.
    >> Share


  205. Experts Discuss COVID-19-Vaccine Doses, Virus Variants, and More.
    JAMA. 2021 Feb 10. pii: 2776539. doi: 10.1001/jama.2021.1101.
    >> Share

  206. BIANCHI DW, Kaeser L, Cernich AN
    Involving Pregnant Individuals in Clinical Research on COVID-19 Vaccines.
    JAMA. 2021 Feb 10. pii: 2776540. doi: 10.1001/jama.2021.1865.
    >> Share

  207. ADHIKARI EH, Spong CY
    COVID-19 Vaccination in Pregnant and Lactating Women.
    JAMA. 2021 Feb 8. pii: 2776449. doi: 10.1001/jama.2021.1658.
    >> Share

  208. RASMUSSEN SA, Jamieson DJ
    Pregnancy, Postpartum Care, and COVID-19 Vaccination in 2021.
    JAMA. 2021 Feb 8. pii: 2776447. doi: 10.1001/jama.2021.1683.
    >> Share

  209. MEISSNER HC
    A Viral Pandemic, Vaccine Safety, and Compensation for Adverse Events.
    JAMA. 2021 Feb 5. pii: 2776308. doi: 10.1001/jama.2020.26792.
    >> Share

  210. LIVINGSTON EH
    Necessity of 2 Doses of the Pfizer and Moderna COVID-19 Vaccines.
    JAMA. 2021 Feb 3. pii: 2776229. doi: 10.1001/jama.2021.1375.
    >> Share

    January 2021
  211. JEAN-JACQUES M, Bauchner H
    Vaccine Distribution-Equity Left Behind?
    JAMA. 2021 Jan 29. pii: 2776053. doi: 10.1001/jama.2021.1205.
    >> Share

  212. MOORE JP, Offit PA
    SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants.
    JAMA. 2021 Jan 28. pii: 2776039. doi: 10.1001/jama.2021.1114.
    >> Share

  213. LONGHURST CA, Kremer B, Maysent PS
    Rapid Implementation of a Vaccination Superstation.
    JAMA. 2021 Jan 28. pii: 2776038. doi: 10.1001/jama.2021.0801.
    >> Share

  214. SHIMABUKURO T, Nair N
    Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine.
    JAMA. 2021 Jan 21. pii: 2775646. doi: 10.1001/jama.2021.0600.
    >> Share

  215. KUEHN BM
    Drop in Vaccination Causes Surge in Global Measles Cases, Deaths.
    JAMA. 2021;325:213.
    >> Share

  216. ABBASI J
    Broad, Durable Antibody Response in Universal Flu Vaccine Trial.
    JAMA. 2021;325:121.
    >> Share

  217. LARGENT EA, Miller FG
    Problems With Paying People to Be Vaccinated Against COVID-19.
    JAMA. 2021 Jan 6. pii: 2775005. doi: 10.1001/jama.2020.27121.
    >> Share

  218. LAURING AS, Hodcroft EB
    Genetic Variants of SARS-CoV-2-What Do They Mean?
    JAMA. 2021 Jan 6. pii: 2775006. doi: 10.1001/jama.2020.27124.
    >> Share

  219. GOSTIN LO
    A 7-Point Action Agenda to End the COVID-19 Pandemic for President-elect Biden.
    JAMA. 2021;325:17-18.
    >> Share

    December 2020
  220. GOSTIN LO, Salmon DA, Larson HJ
    Mandating COVID-19 Vaccines.
    JAMA. 2020 Dec 29. pii: 2774712. doi: 10.1001/jama.2020.26553.
    >> Share

  221. SZILAGYI PG, Thomas K, Shah MD, Vizueta N, et al
    National Trends in the US Public's Likelihood of Getting a COVID-19 Vaccine-April 1 to December 8, 2020.
    JAMA. 2020 Dec 29. pii: 2774711. doi: 10.1001/jama.2020.26419.
    >> Share

  222. RUBIN R
    Pharmacies Partner With HHS to Provide COVID-19 Vaccines.
    JAMA. 2020;324:2475.
    >> Share

  223. KUEHN BM
    Global Regulators Set Standards for Safe Vaccines.
    JAMA. 2020;324:2356.
    >> Share


  224. Experts Discuss COVID-19: Vaccine Allocation, Placebo Groups, and More.
    JAMA. 2020;324:2354-2355.
    >> Share

  225. KRIST AH, Davidson KW, Mangione CM, Barry MJ, et al
    Screening for Hepatitis B Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2020;324:2415-2422.
    >> Share

  226. JIN J
    Screening for Hepatitis B in Nonpregnant Adolescents and Adults.
    JAMA. 2020;324:2452.
    >> Share

  227. RID A, Lipsitch M, Miller FG
    The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials.
    JAMA. 2020 Dec 14. pii: 2774382. doi: 10.1001/jama.2020.25053.
    >> Share

  228. VOLPP KG, Loewenstein G, Buttenheim AM
    Behaviorally Informed Strategies for a National COVID-19 Vaccine Promotion Program.
    JAMA. 2020 Dec 14. pii: 2774381. doi: 10.1001/jama.2020.24036.
    >> Share

  229. JOFFE S
    Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines.
    JAMA. 2020 Dec 14. pii: 2774383. doi: 10.1001/jama.2020.25127.
    >> Share

  230. PATEL MM, Uyeki TM
    Influenza Vaccine for Patients With High-risk Cardiovascular Disease.
    JAMA. 2020 Dec 4. pii: 2773988. doi: 10.1001/jama.2020.23948.
    >> Share

  231. VARDENY O, Kim K, Udell JA, Joseph J, et al
    Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial.
    JAMA. 2020 Dec 4. pii: 2773989. doi: 10.1001/jama.2020.23649.
    >> Share

  232. RODRIGUES FMP, Marlow R, Simoes MJ, Danon L, et al
    Association of Use of a Meningococcus Group B Vaccine With Group B Invasive Meningococcal Disease Among Children in Portugal.
    JAMA. 2020;324:2187-2194.
    >> Share

    November 2020
  233. DESAI AN, Majumder MS
    What Is Herd Immunity?
    JAMA. 2020;324:2113.
    >> Share

  234. LURIE N, Experton B
    How to Leverage the Medicare Program for a COVID-19 Vaccination Campaign.
    JAMA. 2020 Nov 19. pii: 2773348. doi: 10.1001/jama.2020.22720.
    >> Share

  235. LENIS AT, Lec PM, Chamie K, Mshs MD, et al
    Bladder Cancer: A Review.
    JAMA. 2020;324:1980-1991.
    >> Share

  236. SLOMSKI A
    New Guideline Calls for Cervical Cancer Screening to Begin at Age 25 Years.
    JAMA. 2020 Nov 6. pii: 2772859. doi: 10.1001/jama.2020.21706.
    >> Share

  237. UYEKI TM
    High-risk Groups for Influenza Complications.
    JAMA. 2020 Nov 2. pii: 2772692. doi: 10.1001/jama.2020.21869.
    >> Share

  238. UYEKI TM, Santoli J, Jernigan DB
    Preparing for the 2020-2021 Influenza Season.
    JAMA. 2020 Nov 2. pii: 2772691. doi: 10.1001/jama.2020.21849.
    >> Share

    October 2020
  239. JAKLEVIC MC
    Nursing Homes' Next Test-Vaccinating Workers Against COVID-19.
    JAMA. 2020 Oct 28. pii: 2772581. doi: 10.1001/jama.2020.21354.
    >> Share

  240. BELL BP, Romero JR, Lee GM
    Scientific and Ethical Principles Underlying Recommendations From the Advisory Committee on Immunization Practices for COVID-19 Vaccination Implementation.
    JAMA. 2020 Oct 22. pii: 2772326. doi: 10.1001/jama.2020.20847.
    >> Share

  241. LEE GM, Romero JR, Bell BP
    Postapproval Vaccine Safety Surveillance for COVID-19 Vaccines in the US.
    JAMA. 2020 Oct 16. pii: 2772137. doi: 10.1001/jama.2020.19692.
    >> Share

  242. GOODMAN JL, Grabenstein JD, Braun MM
    Answering Key Questions About COVID-19 Vaccines.
    JAMA. 2020 Oct 16. pii: 2772138. doi: 10.1001/jama.2020.20590.
    >> Share

  243. PATEL MM, Jackson ML, Ferdinands J
    Postlicensure Evaluation of COVID-19 Vaccines.
    JAMA. 2020 Oct 16. pii: 2772136. doi: 10.1001/jama.2020.19328.
    >> Share

  244. SCHMIDT H, Gostin LO, Williams MA
    Is It Lawful and Ethical to Prioritize Racial Minorities for COVID-19 Vaccines?
    JAMA. 2020 Oct 14. pii: 2771874. doi: 10.1001/jama.2020.20571.
    >> Share


  245. Influenza Vaccine for 2020-2021.
    JAMA. 2020 Oct 2. pii: 2771510. doi: 10.1001/jama.2020.19507.
    >> Share

    September 2020
  246. STEPHENS DS, McElrath MJ
    COVID-19 and the Path to Immunity.
    JAMA. 2020 Sep 11. pii: 2770758. doi: 10.1001/jama.2020.16656.
    >> Share

    August 2020
  247. SOLOMON DA, Sherman AC, Kanjilal S
    Influenza in the COVID-19 Era.
    JAMA. 2020 Aug 14. pii: 2769676. doi: 10.1001/jama.2020.14661.
    >> Share

    July 2020
  248. WIERSINGA WJ, Rhodes A, Cheng AC, Peacock SJ, et al
    Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.
    JAMA. 2020 Jul 10. pii: 2768391. doi: 10.1001/jama.2020.12839.
    >> Share

  249. DESAI AN, Kim AY
    Management of Hepatitis A in 2020-2021.
    JAMA. 2020 Jul 6. pii: 2768154. doi: 10.1001/jama.2020.4017.
    >> Share

    May 2020
  250. DEL RIO C, Malani P
    Translating Science on COVID-19 to Improve Clinical Care and Support the Public Health Response.
    JAMA. 2020 May 22. pii: 2766600. doi: 10.1001/jama.2020.9252.
    >> Share

  251. HALL MA, Studdert DM
    Privileges and Immunity Certification During the COVID-19 Pandemic.
    JAMA. 2020 May 6. pii: 2765835. doi: 10.1001/jama.2020.7712.
    >> Share

  252. PERSAD G, Emanuel EJ
    The Ethics of COVID-19 Immunity-Based Licenses ("Immunity Passports").
    JAMA. 2020 May 6. pii: 2765836. doi: 10.1001/jama.2020.8102.
    >> Share

    February 2020
  253. WONG JEL, Leo YS, Tan CC
    COVID-19 in Singapore-Current Experience: Critical Global Issues That Require Attention and Action.
    JAMA. 2020 Feb 20. pii: 2761890. doi: 10.1001/jama.2020.2467.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016